Search

everythinglearnresearchcommunity

for

Search:↓

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Malassezia-associated dermatitis can cause itching in cats with feline paraneoplastic alopecia.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The cat had a rare condition linked to cancer, leading to its euthanasia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.